Events in 2022

Chair: Dr Guy Orchard
14.00
Immunohistochemistry (IHC) in breast pathology
Keeley Thwaites, Barking Havering and Redbridge University Hospitals NHS Trust
14.30 Lymphoma pathology:
The impact of immunohistochemistry, past and present
Dr José Cabeçadas’s, Oncology Institute of Lisbon, Portugal
16.00 Head and neck pathology: A new module from UK
NEQAS for ICC & ISH
Suzanne Parry,
UK NEQAS ICC & ISH
16.30 Clinical aspects of head and neck pathology
Dr Ann Sandison, Guy’s and St.Thomas’ NHS Foundation Trust

Chair: Ashley Ballard
9.00 Consultant scientist reporting
– 2 years on
Patrick Kumah, University Hospitals of Derby and Burton NHS Foundation Trust
9.30 Genomic testing in histopathology: An ethical perspective Dr Mahomed Dada,
University Hospitals of Derby & Burton NHS Foundation Trust
10.30
Instrumentation – friend or foe?
Rob Hughes, UK NEQAS Cellular Pathology Technique
11.00 Digital pathology – pilot to practice
William Davies, Worcestershire Acute Hospitals NHS Trust
11.30 Digital pathology – to infinity and beyond
Dr David Brettle, Leeds Cancer Centre, St. James’s University Hospital

Chair: Graham Wilson
14.00 Future of Clinical Biochemistry
– health informatics and bioinformatics Prof. Dimitris Grammatopoulos, Warwick Medical School and University Hospitals of Coventry and Warwickshire NHS Trust
14.30 A case of pseudohyperkalaemia and pseudo- hypercalcaemia in a patient with acute myeloid leukaemia with thrombocytosis Andrew Connor, PathLinks, North
East Lincolnshire and Goole NHS Foundation Trust
14.50 A case of myeloma diagnosed from a random urine protein
Charlotte Atkin, Nottingham University Hospitals NHS Trust
15.10 A biochemistry Biomedical Scientist
– roles and career development beyond the laboratory Sheri Scott, Nottingham Trent University
16.00 Liver Pandemic
- Can the Laboratory save us?
Dr Andrew Fraser, Queen Elizabeth University Hospital, Glasgow
16.30 Biochemical screening for phaeochromocytoma and paraganglioma (PPGL)
Dr Craig Livie, NHS Greater Glasgow and Clyde

Chair: Martin McFadden
9.00 Tumour markers for today and tomorrow
Prof. Joe Duffy, St Vincent’s University Hospital, Dublin
9.30 Essential contribution of laboratory diagnostics in COVID-19
Prof. Giuseppe Lippi, University of Verona, Italy
10.30 Biomarkers in the diagnosis of sepsis
Andrew Teggert, South Tees Hospitals NHS Foundation Trust
11.00 Urgent Biochemistry – impact of the 1 hour TAT
in the ED, does it benefit patients? Prof. Richard Body, University of Manchester
11.30 COVID-19: Cross skilling of healthcare workers Becky Kay, Guy’s and St Thomas’ NHS Foundation Trust 12.45 Clinical Scientist Experiential Route and Process and
Q&A with the Clinical Chemistry Higher Specialist Diploma (HSD) Examiners
Jamie West, North West Anglia NHS Foundation Trust; Sheri Scott, Nottingham Trent University; Jennie Kettlewell, York Teaching Hospital
NHS Foundation Trust and Dr Nigel Brown, Wansbeck General Hospital

Diagnostic cytopathology
Chair: Alison Malkin
14.00 Molecular diagnostics in lung cytology
Dr Anca Oniscu, NHS Lothian
14.30 Molecular diagnostics in Thyroid
Dr Anca Oniscu, NHS Lothian
15.00 IBMS Specialist Portfolio in Diagnostic Pathology Tracey Stevenson, Royal Devon & Exeter NHS Foundation Trust
16.00 Liquid Based Cytology - Rapid molecular testing using the Biocartis Idylla Platform Leonie Wheeldon, Royal Cornwall Hospital NHS Trust
16.30 DEP & ASD in diagnostic cytology exam preparation Dr Behdad
Shambayati, Berkshire & Surrey Pathology Services

Diagnostic cytopathology
Chair: Gary Collins
9.00 Bile duct brushings
– LBC versus clinician- prepared slides Hedley Glencross,
formerly of Portsmouth Hospitals University NHS Trust
9.30 ROSE - The role of biomedical scientist in On Site Assessment of sample adequacy
Dr Anita Jayadev, Frimley Health NHS Foundation Trust
10.30 Experimenting with Digital Cytology: One lab’s experience Dr Cynthia Van der Horst, NHS Greater Glasgow & Clyde, Queen Elizabeth Univeristy Hospital
11.00 Diagnostic Cytology UKNEQAS interpretive EQA scheme
John Crossley, UK NEQAS
11.30 Diagnostic Cytology UKNEQAS technical EQA scheme Chantell Hodgson,
UK NEQAS Cellular Pathology Technique
12.45 Diagnostic cytology workshop: Interactive case studies
Dr Behdad Shambayati, Berkshire & Surrey Pathology Services; Tracey Stevenson, Royal
Devon & Exeter NHS
Foundation Trust

Chair: Dr Sukhjinder Marwah
Red cells 14.00
Haemoglobinopathy conundrums - small details, big difference! Daniel Monteiro, Viapath – An NHS partnership with SYNLAB
14.30 Standardised testing for Paroxysmal Haemoglobinuria Daniel Payne, Haematological Malignancy Diagnostic Service, The Leeds Teaching Hospitals NHS Trust
15.00 Gene therapy and bone marrow transplant treatment in beta halassaemia patients
Prof. Josu De La Fuente, Imperial College Healthcare NHS Trust
Haemostatasis
16.00 Impact of COVID-19 on the haemostasis lab testing
Minal Dave, Barts Health NHS Trust
16.30 Rebalancing the scales
Dr David Gurney, University Hospitals Birmingham NHS Foundation Trust

Chair: Dr David Gurney
COVID-19
9.00 Gene therapy: Curing the incurable! Dr Rashid Kazmi, University Hospital Southampton NHS Foundation Trust
9.30 Anticoagulation in COVID-19: What does not kill
Dr Andrew Godfrey, The Royal Marsden NHS Foundation Trust
Haemostasis
10.30 The rise of misinformation and the role of science education
Rev Dr Gordon Sinclair, London Metropolitan University
11.00 Q&A. What we learnt from COVID-19 Dr Steve Kitchen and Dr Annette Bowyer, The Royal Hallamshire Hospital; and Dr Gary Moore, Technoclone

Chair: Sean Conlan
14.00 Human leucocyte antigen epitopes
Dr Richard Battle, Scottish National Blood Transfusion Service
14.30 Clinical applications of the predicted indirectly recognisable HLA epitopes (PIRCHE) software tool in solid organ and bone marrow transplant Neil Marsden, Leeds Teaching Hospitals NHS Trust
15.00 Cell and Gene therapy: Manufacturing support to the NHS
Dr Katy Latham, NHS Blood & Transplant
16.00 Genomics of inborn errors of
immunity - from rare variants to clinically actionable findings Prof. Sophie Hambleton, Newcastle University and Newcastle Upon Tyne Hospitals NHS Foundation Trust

Chair: Dina Patel
9.00 Neuroscience laboratories services Katherine Birch, The Walton Centre NHS Foundation Trust
9.30 Testing for the investigation of myasthenia gravis Dr Ross Sadler, Oxford University Hospitals NHS Foundation Trust
10.30 Myositis antibodies: Are we missing something?
11.00 Autoimmune bullous dermatoses: beyond the green screen
Dr John Mee, Viapath Analytics - An NHS partnership with SYNLAB
11.30 Serological testing for immune- mediated lung disease
Dr Adrian Heaps, North Cumbria Integrated Care NHS Trust